Explores emulsification and wound healing properties of jellyfish collagen, suggesting versatile biomedical applications.
Jellyfish collagen, a sustainable and biocompatible marine biomaterial, holds great potential in food and biomedical applications. This study explores the emulsification properties and therapeutic potential of pepsin-soluble collagen derived from salt-preserved Rhopilema esculentum (RPSC). Structural analysis confirmed that RPSC retained an intact triple-helix structure with a denaturation temperature of approximately 36.0 °C and formed elastic gels at concentrations ≥1.5% (w/w). As an emulsion stabilizer, RPSC (2%, w/w) effectively stabilized oil-in-water emulsions with oil fractions up to 50%, forming viscoelastic networks that exhibited excellent centrifugal stability but limited freeze–thaw tolerance. The gel–sol transition occurred near 38.0 °C, consistent with the thermal denaturation of RPSC. As a wound healing promoter, RPSC showed no cytotoxicity and dose-dependently enhanced 3T3 fibroblast viability, migration, and SOD activity. Notably, RPSC downregulated TGF-β1 expression and suppressed endogenous type I collagen synthesis, indicating a scar-mitigating profile distinct from conventional pro-fibrotic collagen dressings. These findings establish RPSC as a bifunctional marine biomaterial for both emulsified food systems and regenerative wound dressings in the biomedical field.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: